In a majority of murine AAA studies reported, hypercholesterolemia is required for successfully modeling AAA using Ang II (40), either by genetic ablation of apolipoprotein E (Apoe–/–) (41) or LDL receptor (Ldlr–/–) (42). The gene discussed is LDLR; the disease is triple-A syndrome.